Icos co-promotes Solvay's AndroGel in the US
Icos has agreed to co-promote Solvay Pharmaceuticals' AndroGel (testosterone gel 1%) in the US as a replacement therapy for men with a deficiency or absence of natural testosterone. The agreement goes through 2006 and has a renewal option.
- Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.